Screening long-stay psychiatric patients for risk factors for coronary heart disease

International Journal of Therapy and Rehabilitation

Volumn 11, Issue 3, 2004, Pages 113-118

  Haw, Camilla ^a   Merriman, Sheila ^a   Kirk, Judy ^a   Stubbs, Jean ^a  

^a ST ANDREW S HOSPITAL   (United Kingdom)

Author keywords

Coronary heart disease; Hyperlipidaemia; Mental illness; Obesity; Risk factor; Smoking

Indexed keywords

EID: 4143100797     PISSN: 17411645     EISSN: 1759779X     Source Type: Journal    
DOI: 10.12968/ijtr.2004.11.3.13382     Document Type: Article

References (27)

1. Allison D, Mentore J, Moonseong H et al (1999) Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychol 156: 1686-96
2. Aquila R, Emanuel M (2000) Interventions for weight gain in adults treated with novel antipsychotics. Prim Care Companion J Clin Psychiatr 2: 20-3
3. Black AE, Cole TJ (2001) Biased over-or under-reporting is characteristic of individuals whether over time or by different assessment methods. J Am Diet Assoc 101: 70-80
4. British Heart Foundation (1999) Joint British Societies Coronary Risk Prediction Chart. British Heart Foundation and British Cardiac Society, London
5. British Medical Association and Royal Pharmaceutical Society of Great Britain (2001) British National Formulary Number 42. BMJ Books, London
6. Brown S, Inskip H, Barraclough B (2000) Causes of the excess mortality of schizophrenia. Br J Psychol 177: 212-7
7. Davidson S, Judd F, Jolley D, Hocking B, Thompson S, Hyland B (2001) Cardiovascular risk factors for people with mental illness. Aust N Z J Psychol 35: 196-202
8. Department of Health (1999) Health Survey for England. Department of Health, London
9. Department of Health (2000) National Service Framework for Coronary Heart Disease. Department of Health, London
10. Devlin M, Yanovski S, Wilson G (2000) Obesity: what mental health professionals need to know. Am J Psychol 157: 854-66
11. Henderson D, Cagliero E, Gray C et al (2000) Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: a five-year naturalistic study. Am J Psychol 157: 975-81
12. Hughes J, Hatsukami D, Mitchell J, Dahlgren L (1986) Prevalence of smoking among psychiatric outpatients. Am J Psychol 143: 993-7
13. Kendrick T (1996) Cardiovascular and respiratory risk factors and symptoms among general practice patients with long-term mental illness. Br J Psychol 169: 733-9
14. Knox J (1980) A study of weight reducing diets in psychiatric in-patients. Br J Psychol 136: 287-9
15. Knutsen E, DuRand C (1991) Previously unrecognised physical illness in psychiatric patients. Hosp Commun Psychiatr 42: 182-6
16. Koro C, Fedder D, L’Italien G et al (2002) Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study. Br Med J 325: 243-5
17. Lakka HM, Lakka TA, Tuomilehto J, Salonen JT (2002) Abdominal obesity is associated with increased risk of coronary events in men. Eur Heart J 23(9): 706-13
18. Lawrence DM, Holman CD, Jablensky AV, Hobbs MS (2003) Death rate from ischaemic heart disease in Western Australian psychiatric patients 1980-1998. Br J Psychiatr 182(1): 31-6
19. Meiklejohn C, Sanders K, Butler S (2003) Physical health care in medium secure services. Nurs Stand 17: 33-7
20. Melkersson K, Hulting A, Brismar K (2000) Elevated levels of insulin, leptin, and blood lipids in olanzapine-treated patients with schizophrenia or related psychoses. J Clin Psychol 61: 742-9
21. Taylor D, McAskill R (2000) Atypical antipsychotics and weight gain-a systematic review. Acta Psychiatr Scand 101: 416-32
22. Thomas B (2001) Manual of Dietetic Practice. Blackwell Science, Oxford
23. Willett W, Dietz W, Colditz G (1999) Guidelines for healthy weight. N Engl J Med 341: 427-33
24. Wood D, Durrington P, Poulter N, McInnes G, Rees A, Wray R (1998) Joint British recommendations on prevention of coronary heart disease in clinical practice. Heart 80(suppl. 2): S1-29
25. World Health Organization (1998) Obesity. Preventing and Managing the Global Epidemic. World Health Organization, Geneva
26. World Health Organization (1999) Definitions, Diagnosis and Classification of Diabetes Mellitus and its Complications.World Health Organization, Geneva
27. Yorston G, Pinney A (2000) Chlorpromazine equivalents and percentage of British National Formulary maximum recommended dose in patients receiving high dose antipsychotics. Psychol Bull 24: 130-2